MoneyWorks4Me

Kopran - Quaterly Results

10 Aug 2022 Evaluate
The total revenue for the June 2022 quarter zoomed 143.60% to Rs. 711.80 millions as compared to Rs. 292.20 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 336.74% to Rs. 38.04  millions  from Rs. 8.71 millions in previous same quarter.OP of the company witnessed a marginal growth to 66.56 millions from 28.73 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 711.80 292.20 143.60 711.80 292.20 143.60 2045.20 2228.33 -8.22
Other Income 1.73 23.51 -92.64 1.73 23.51 -92.64 80.27 104.14 -22.92
PBIDT 66.56 28.73 131.67 66.56 28.73 131.67 234.40 406.14 -42.29
Interest 4.95 6.55 -24.43 4.95 6.55 -24.43 29.53 38.07 -22.43
PBDT 61.61 22.18 177.77 61.61 22.18 177.77 204.87 368.07 -44.34
Depreciation 10.81 10.77 0.37 10.81 10.77 0.37 43.23 41.03 5.36
PBT 50.80 11.41 345.22 50.80 11.41 345.22 161.64 327.04 -50.57
TAX 12.76 2.70 372.59 12.76 2.70 372.59 44.20 92.33 -52.13
Deferred Tax -1.02 0.71 -243.66 -1.02 0.71 -243.66 6.73 34.76 -80.64
PAT 38.04 8.71 336.74 38.04 8.71 336.74 117.44 234.71 -49.96
Equity 482.11 432.52 11.47 482.11 432.52 11.47 482.12 432.52 11.47
PBIDTM(%) 9.35 9.83 -4.90 9.35 9.83 -4.90 11.46 18.23 -37.12
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..